Skip to content

Price / earnings at other companies

Abbott logo
AbbottABT
29.1×+11.9×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
44.6×
Danaher logo
DanaherDHR
33.7×-7.7×
OraSure Technologies logo
OraSure TechnologiesOSUR
27.9×-168×
Revvity logo
RevvityRVTY
40.9×-3.5×
Quest Diagnostics logo
Quest DiagnosticsDGX
22.1×+1.0×

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$1.15B-35.0%
Enterprise value$4.11B-13.1%
P/S0.4×-0.2×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Calculated from QuidelOrtho Corporation’s reported figures.

Based on the most recent quarter.

The official record: QuidelOrtho Corporation’s 10-Q, filed November 8, 2024, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's price / earnings?
QuidelOrtho Corporation (QDEL) reported price / earnings of 309.6× in Q3 2023.
How has QuidelOrtho Corporation's price / earnings changed year-over-year?
QuidelOrtho Corporation's price / earnings increased by 4068.0% year-over-year, from 7.4× to 309.6×.
What is the long-term trend for QuidelOrtho Corporation's price / earnings?
Over 2 years (2020 to 2022), QuidelOrtho Corporation's price / earnings has grown at a -10.7% compound annual growth rate (CAGR), from 12.9× to 10.3×.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.